Jefferies Financial Group issued updated stock ratings and target prices for Tango Therapeutics, Inc., alongside an insider sale.
4 reports, 2 independent
Updated Wed 00:00
No new developments lately
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies Financial Group issued updated stock ratings and target prices for Tango Therapeutics, Inc., alongside an insider sale.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Multiple firms, including BlackRock and Jupiter Topco, acquired new stakes in Tango Therapeutics.1 source
Jefferies adjusted ratings for Tango Therapeutics and reported an insider stock sale.1 source
Keep exploring
The entities involved
-
Jefferies Financial Group
American financial services company
Related events
- Jefferies Financial Group increased its price target for Procter & Gamble stock, according to MarketScreener.
- Jefferies Financial Group initiated coverage on Moody's shares, and Morgan Stanley subsequently raised its price target for the company.
- General Counsel of Arthur J. Gallagher & Co. sold company stock, while major banks issued rating and price target updates.
- BHC received a 'hold' rating from Jefferies, while MarketBeat provided consensus data and the board initiated a stock buyback plan.
- Jefferies Financial Group set a price target for Navitas Semiconductor stock.